Have We Underestimated What Menopause Really Is?
For years, menopause has been reduced to two headline symptoms. Hot flushes and mood swings. Yet clinical research tells a far more complex story. In the United Kingdom alone, over 13 million women are peri- or post-menopausal.
Globally, nearly 85 percent of women experience symptoms that affect daily life, work performance, sleep, relationships, cognition and physical health.
Still, many women are left wondering “Is this really menopause… or is something wrong with me?”
Let us pause and look again.
Menopause is not simply a hormonal event. It is a whole-body recalibration driven by fluctuating and declining oestrogen, progesterone and testosterone.
These hormones influence the brain, cardiovascular system, skin, bladder, immune function and even the microbiome. When they shift, everything connected to them shifts too.
Brain Changes Are Measurable
If you did not know, here is what often goes unspoken.
Cognitive changes such as brain fog are not imagined. Oestrogen plays a protective role in neurotransmitter function, including serotonin and dopamine pathways.
Research from the Study of Women’s Health Across the Nation (SWAN) shows that many women report measurable cognitive changes during perimenopause, particularly in verbal memory and processing speed.
Neuro imaging research led by Dr Lisa Mosconi demonstrates that menopause is associated with observable changes in brain metabolism. The brain is adapting to a new hormonal environment.
For high-functioning women in leadership, this often shows up long before it is recognised as hormonal.
What We Rarely Discuss
If you forgot, here is your reminder.
Menopause affects the eyes, ears and mouth. Dry eyes, subtle changes in vision, vertigo, tinnitus and even burning mouth syndrome are recognised but rarely discussed symptoms. These are linked to mucosal tissue changes and neurological sensitivity influenced by hormone decline.
These symptoms are not culturally associated with menopause, many women seek multiple referrals without anyone connecting the dots.
The Cardiovascular and Respiratory Dimension
If you need a deeper understanding, consider the cardiovascular and respiratory shifts.
Heart palpitations and shortness of breath can occur because oestrogen influences vascular elasticity and autonomic nervous system regulation. The British Menopause Society reports that up to 54 percent of women experience palpitations during the transition.
Oestrogen also plays a protective role in cardiovascular health. After menopause, the risk of cardiovascular disease rises significantly. This is not minor. Heart disease remains the leading cause of death for women in the United Kingdom.
Persistent and Under-Treated
Then there is the urogenital system.
Vaginal dryness, recurrent urinary tract infections, bladder urgency and reduced libido are not separate issues. They are part of Genitourinary Syndrome of Menopause. Research suggests up to 50 percent of post-menopausal women experience these symptoms, yet fewer than a third seek treatment.
The tissue lining the bladder and vagina becomes thinner and less elastic when oestrogen declines. Without treatment, symptoms often persist rather than resolve.
The Intersectional Impact
This is where the conversation deepens.
Research from the SWAN study found that Black women experience menopause symptoms for longer durations, often reporting more frequent and intense vasomotor symptoms such as hot flushes.
Some studies suggest symptoms can last up to 8 to 10 years on average, with longer persistence in Black women compared to White women.
Women of colour also face structural disparities in healthcare access, delayed diagnosis, and lower rates of Hormone Replacement Therapy prescription. Cultural stigma around discussing reproductive health further compounds silence.
In the United Kingdom, Black women have higher prevalence rates of hypertension and cardio metabolic risk. When menopause-related cardiovascular changes are layered onto pre-existing disparities, the health impact becomes amplified.
This is not simply about hormones. It is about equity.
The Workplace and Leadership Consequences
Nearly 1 in 10 women in the United Kingdom have left a job because of menopause symptoms, according to government data. Many more reduce hours, step back from leadership pathways or avoid promotions altogether.
The economic impact is not marginal. Estimates suggest menopause-related symptoms cost the United Kingdom economy between £1.5 billion and £1.9 billion annually due to absenteeism, presenteeism and women leaving the workforce.
That equates to approximately 14 million lost working days each year. Around 60,000 women are currently not in employment because of menopause symptoms alone.
This is not simply a personal health issue. It is a structural workforce issue. It is lost experience at peak career years. It is leadership capacity quietly exiting the system.
For Black and minority ethnic women, who are already under-represented in senior leadership roles, unmanaged menopause symptoms intersect with racial bias, stereotype threat and increased performance scrutiny.
Research consistently shows that Black women experience vasomotor symptoms such as hot flushes for longer durations on average, meaning the workplace impact may be extended over more years.
When cognitive shifts are misinterpreted as incompetence rather than hormonal adaptation, the consequences can affect income, confidence and career trajectory. For women already navigating bias, that misinterpretation can accelerate marginalisation.
When nearly £2 billion in productivity is at stake each year, menopause is no longer a wellbeing conversation. It is a national economic and leadership retention strategy.
The Biological Cascade
Skin changes, itching, altered body odour, tingling extremities, migraines, sore breasts and cold flushes are part of the same biological cascade.
This is not exaggeration. It is physiology.
The problem is not that women are weak. The problem is that menopause education has been incomplete. So perhaps the better question for this group is this “How many of these symptoms have you normalised, minimised or misattributed to stress, ageing” or “just being busy?”
Awareness Changes Outcomes.
When women understand the full spectrum, they can advocate for appropriate support whether that is lifestyle intervention, Hormone Replacement Therapy (HRT), nutrition, pelvic floor therapy, cognitive strategies or simply informed reassurance.
But awareness cannot stop at the individual.
Take a moment today. Look at the list. Reflect honestly.
Where are you right now?
What step could you take this month to better understand your own body rather than pushing through in silence?
Now take the reflection one level higher.
What policies in your workplace acknowledge this transition?
What protections exist in your organisation?
What data is being collected?
What conversations are still being avoided?
Unless organisations adapt policies to reflect biological reality, the financial, professional and emotional cost will continue to be absorbed privately by women.
If nearly £2 billion in productivity is lost annually and thousands of experienced women step back from their careers, then this is not about coping better. It is about structural design.
Until institutions adapt to biological reality, women will continue to absorb the cost privately.
Awareness is the beginning. Policy is the shift.
If this resonated with you, comment with one word that describes where you are in your journey. Share this with another woman who needs to see it. Let us move this conversation from silence to strategy.
